Our History

Our History 2017-06-07T18:33:00+00:00

Over 25 years in ART


ORIGIO was founded in Denmark in 1987 under the name Medicult. Its innovative approach quickly positioned it as one of the leaders in the global IVF Media market. In 2012, the company was acquired by CooperSurgical, global leader in medical devices for women’s health, and part of the Cooper Companies group.
ORIGIO employs over 400 people, has 16 subsidiaries, and markets its products in more than 100 countries.

ORIGIO-Training-Lab-core-embryology

2016

Acquisition by CooperSurgical of Wallace, the gold standard of embryo transfer catheters and oocyte retrieval needles.
Acquisition by CooperSurgical of The Pipette Company Pty. Ltd, a respected manufacturer and distributor of micro pipettes for the ART market.
Acquisition by CooperSurgical of K-Systems Kivex Biotec A/S, a market leader in developing, manufacturing and distribution of innovative and expertly designed equipment to IVF clinics.
Launch of VitriFit, open system vitrification carrier, optimizing storage efficiency.
Launch of Spherical tip catheter, a pre-angled catheter with a sphere at the tip for optimal, atraumatic embryo transfer.

2015

Acquisition by CooperSurgical of Research Instruments Ltd., a leading manufacturer and supplier of IVF medical devices, hardware such as micromanipulators, lasers, as well as security and ART management systems.
Launch of EmbryoGen® and BlastGen, novel culture media suite containing the recombinant human GM-CSF cytokine.
Launch of EchoGen catheter for enhanced visibility under ultrasound-assisted embryo transfer.

2014

Launch of ORIGIO® Sequential Series, optimized culture media series for sequential culture.
Launch of SAGE 1-Step, single step medium for uninterrupted embryo culture.

2012

Acquisition of ORIGIO by CooperSurgical, leader in medical devices for women’s health, and part of the Cooper Companies group.

2011

Acquisition of Artworks B.V., manufacturer of IVF oocyte retrieval needles and embryo transfer catheters.
Launch of EmbryoGen®, culture medium for cleavage-stage embryos containing the recombinant human GM-CSF cytokine.

2009

MediCult becomes ORIGIO.

2008

Acquisition of MidAtlantic Diagnostics, leader in devices and equipment for ART.

2007

Acquisition of Humagen Fertility Diagnostics, the first name in micropipettes, and leading brand.

1988

Launch of Universal IVF Medium for fertilization and culture until 2-8 cell stage.
Launch of Flushing Medium for retrieval, holding and washing of oocytes.
Launch of Sperm Preparation Medium for sperm wash and isolation of motile viable sperm by swim-up.

1987

Foundation of MediCult based on pioneered SSR® technology.